Montauk Renewables, Inc. (MNTK) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. Montauk Renewables, Inc. is a renewable energy company specializing in the recovery and conversion of biogas (landfill gas and anaerobic digested gas) into Renewable Natural Gas (RNG) and Renewable Electricity. The company operates 13 projects across seven states. It is classified as an Accelerated Filer and an Emerging Growth Company.
Key Financial Metrics (Six Months Ended June 30, 2026)
| Metric | Value (in thousands) |
|---|---|
| Total Operating Revenues | $100,447 |
| Net Income | $231 |
| Operating Loss | $(1,675) |
| Adjusted EBITDA | $23,090 |
| Cash Flow from Operations | $30,445 |
| Cash and Cash Equivalents | $15,757 |
| Total Debt (Principal) | $155,000 |
| Capital Expenditures | $55,560 |
Material Changes vs. Prior Period
- Revenue Growth: Total operating revenues increased 14.5% to $100.4 million compared to $87.7 million in the prior year period. This was primarily driven by approximately $12.6 million in revenue from RINs distributed by the GreenWave joint venture, which had no such activity in the prior year.
- Profitability Turnaround: The company reported a net income of $231,000, a significant improvement from a net loss of $5.95 million in the same period in 2025. This turnaround was largely due to income from the GreenWave joint venture ($7.09 million) and reduced impairment losses.
- Debt Refinancing: On March 9, 2026, the company entered a new five-year Senior Credit Facility with Hannon Armstrong Capital LLC (HASI) for up to $200 million. This refinanced all prior debt, resulting in a $944,000 loss on extinguishment of debt. The new facility carries a fixed interest rate of 10.25%.
- Impairment Reduction: Impairment losses decreased by 54.9% to $1.09 million from $2.42 million in the prior year, as 2025 impairments included a significant write-off of a development project interconnection.
- Operating Expenses: Operating and maintenance expenses increased 32.5% to $52.2 million, primarily due to costs associated with the GreenWave joint venture ($12.6 million) and non-capitalizable costs at the Montauk Ag Renewables project.
Guidance, Outlook, and Risks
- Development Pipeline: The company expects 2026 development capital expenditures to range between $80 million and $100 million, focusing on the Montauk Ag Renewables project, Bowerman RNG, Rumpke RNG Relocation, Atascocita CO2, and Tulsa RNG projects.
- Montauk Ag Renewables: The Turkey, NC facility began generating power in July 2026. The company is negotiating REC sales contracts, with a signed agreement for 47 RECs with Duke Energy. Full first-stage production is expected to generate approximately 120 RECs annually.
- Regulatory Risks: The company faces risks related to EPA Renewable Fuel Standard (RFS) volume requirements and potential legal challenges to 2026/2027 standards. Additionally, California's LCFS rules are becoming more stringent, which could impact credit volumes.
- Operational Risks: Production is subject to feedstock quality and wellfield extraction issues at specific sites (e.g., McCarty and Apex facilities). The company notes that landfill hosts delaying wellfield infrastructure installation could impact production growth.
- Liquidity: Management believes cash flows from operations and the new credit facility will meet obligations for the next 12-24 months. The new credit facility includes covenants requiring a minimum quarterly trailing EBITDA of $10 million and a minimum D3 RIN price of $1.00.
Investor Verification Checklist
- GreenWave Joint Venture Impact: Verify the sustainability of the $7.1 million income and $12.6 million revenue contribution from the GreenWave joint venture, as this was a new revenue stream absent in the prior year.
- Debt Covenant Compliance: Confirm ongoing compliance with the new HASI credit facility covenants, specifically the $10 million quarterly trailing EBITDA requirement and the $1.00 D3 RIN price floor.
- Montauk Ag Renewables Progress: Monitor the ramp-up of the Turkey, NC facility and the execution of REC sales contracts to ensure projected revenue targets are met.
- RIN Pricing Volatility: Assess the impact of potential regulatory changes to the RFS program and market fluctuations in D3 RIN prices on future margins.
- Capital Expenditure Execution: Track the $80-$100 million development capex plan to ensure projects are completed on schedule and within budget.